75/120
3.1 / 5 stars
All 120 Win/Lose results shown below
LLY Roast Me summary
ELI LILLY & Co (LLY). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 10 wins, 2 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q23/3 |
WinLLY / S&P 30.63% / 15.20% |
WinLLY / S&P 49.58% / 15.00% |
WinLLY / S&P 94.77% / 50.40% |
| 2026-Q12/3 |
LoseLLY / S&P -14.27% / -4.33% |
WinLLY / S&P 47.44% / 11.30% |
WinLLY / S&P 129.05% / 27.70% |
| 2025-Q43/3 |
WinLLY / S&P 41.06% / 2.65% |
WinLLY / S&P 44.70% / 9.00% |
WinLLY / S&P 95.99% / 13.40% |
| 2025-Q32/3 |
LoseLLY / S&P -1.91% / 8.12% |
WinLLY / S&P 45.41% / 4.61% |
WinLLY / S&P 120.97% / 13.45% |
| 2025-Q22/3 |
LoseLLY / S&P -5.42% / 10.94% |
WinLLY / S&P 36.83% / 4.83% |
WinLLY / S&P 88.42% / 10.63% |
| 2025-Q13/3 |
WinLLY / S&P 7.17% / -4.27% |
WinLLY / S&P 36.38% / 4.98% |
WinLLY / S&P 81.00% / 10.57% |
| 2024-Q42/3 |
LoseLLY / S&P -12.72% / 2.41% |
WinLLY / S&P 32.00% / 5.25% |
WinLLY / S&P 101.90% / 6.15% |
| 2024-Q32/3 |
LoseLLY / S&P -2.01% / 5.89% |
WinLLY / S&P 27.41% / 5.89% |
WinLLY / S&P 67.57% / 6.11% |
| 2024-Q23/3 |
WinLLY / S&P 16.58% / 4.28% |
WinLLY / S&P 31.87% / 5.38% |
WinLLY / S&P 12.93% / 5.12% |
| 2024-Q13/3 |
WinLLY / S&P 33.69% / 10.56% |
WinLLY / S&P 29.76% / 5.71% |
WinLLY / S&P 7.95% / 5.59% |
| 2023-Q41/3 |
LoseLLY / S&P 8.73% / 11.69% |
WinLLY / S&P 19.56% / 6.81% |
LoseLLY / S&P -15.94% / 7.78% |
| 2023-Q32/3 |
WinLLY / S&P 14.78% / -3.27% |
WinLLY / S&P 9.69% / 7.52% |
LoseLLY / S&P -16.99% / -5.03% |
| 2023-Q22/3 |
WinLLY / S&P 36.92% / 8.74% |
LoseLLY / S&P 1.53% / 9.50% |
WinLLY / S&P 14.86% / -8.57% |
| 2023-Q11/3 |
LoseLLY / S&P -5.82% / 7.50% |
LoseLLY / S&P -5.56% / 10.77% |
WinLLY / S&P -6.68% / -15.69% |
| 2022-Q42/3 |
WinLLY / S&P 13.46% / 7.56% |
LoseLLY / S&P 0.79% / 11.88% |
WinLLY / S&P 12.75% / -17.99% |
| 2022-Q32/3 |
WinLLY / S&P 0.05% / -4.88% |
LoseLLY / S&P 5.34% / 13.47% |
WinLLY / S&P 1.37% / -1.41% |
| 2022-Q21/3 |
WinLLY / S&P 13.60% / -16.10% |
LoseLLY / S&P 8.77% / 13.71% |
LoseLLY / S&P -6.15% / 11.04% |
| 2022-Q11/3 |
WinLLY / S&P 4.11% / -4.60% |
LoseLLY / S&P 15.06% / 15.97% |
LoseLLY / S&P 0.75% / 42.23% |
| 2021-Q42/3 |
WinLLY / S&P 19.94% / 11.03% |
WinLLY / S&P 15.40% / 15.00% |
LoseLLY / S&P -9.87% / 96.40% |
| 2021-Q32/3 |
WinLLY / S&P 0.99% / 0.58% |
WinLLY / S&P 19.58% / 10.77% |
LoseLLY / S&P 7.01% / 69.42% |
| 2021-Q22/3 |
WinLLY / S&P 23.40% / 8.55% |
WinLLY / S&P 16.46% / 6.58% |
LoseLLY / S&P 8.10% / 51.81% |
| 2021-Q13/3 |
WinLLY / S&P 11.11% / 6.17% |
WinLLY / S&P 10.39% / -1.06% |
WinLLY / S&P 10.40% / 7.39% |
| 2020-Q43/3 |
WinLLY / S&P 14.65% / 12.15% |
WinLLY / S&P 9.95% / -3.72% |
WinLLY / S&P -23.62% / -33.42% |
| 2020-Q32/3 |
LoseLLY / S&P -9.40% / 8.93% |
WinLLY / S&P 6.28% / -2.04% |
WinLLY / S&P -25.43% / -27.10% |
| 2020-Q22/3 |
LoseLLY / S&P 18.91% / 20.54% |
WinLLY / S&P 5.89% / -0.46% |
WinLLY / S&P -22.58% / -27.11% |
| 2020-Q13/3 |
WinLLY / S&P 6.09% / -19.60% |
WinLLY / S&P 6.78% / 3.47% |
WinLLY / S&P -3.50% / -14.75% |
| 2019-Q42/3 |
WinLLY / S&P 18.20% / 9.07% |
LoseLLY / S&P 3.84% / 5.36% |
WinLLY / S&P 184.03% / 2.99% |
| 2019-Q32/3 |
LoseLLY / S&P 1.50% / 1.70% |
WinLLY / S&P 14.25% / 5.02% |
WinLLY / S&P 1648.94% / 0.21% |
| 2019-Q21/3 |
LoseLLY / S&P -14.14% / 4.30% |
WinLLY / S&P 11.32% / 6.64% |
LoseLLY / S&P LLY unavailable / 8.65% |
| 2019-Q12/3 |
LoseLLY / S&P 12.74% / 13.65% |
WinLLY / S&P 9.70% / 8.12% |
WinLLY / S&P 481.48% / 14.29% |
| 2018-Q41/3 |
WinLLY / S&P 8.38% / -13.52% |
LoseLLY / S&P 7.61% / 9.05% |
LoseLLY / S&P LLY unavailable / 18.23% |
| 2018-Q31/3 |
WinLLY / S&P 26.45% / 7.71% |
LoseLLY / S&P -14.92% / 10.21% |
LoseLLY / S&P -77.73% / 19.06% |
| 2018-Q21/3 |
WinLLY / S&P 11.05% / 3.43% |
LoseLLY / S&P -11.52% / 9.03% |
LoseLLY / S&P -105.19% / 14.46% |
| 2018-Q10/3 |
LoseLLY / S&P -7.71% / -0.76% |
LoseLLY / S&P -8.69% / 7.68% |
LoseLLY / S&P -47.83% / 12.46% |
| 2017-Q40/3 |
LoseLLY / S&P -0.64% / 6.64% |
LoseLLY / S&P -5.88% / 7.03% |
LoseLLY / S&P -107.36% / 13.82% |
| 2017-Q32/3 |
WinLLY / S&P 4.60% / 4.48% |
WinLLY / S&P 7.84% / 5.68% |
LoseLLY / S&P -8.26% / 17.57% |
| 2017-Q21/3 |
LoseLLY / S&P -1.52% / 3.09% |
WinLLY / S&P 6.79% / 4.83% |
LoseLLY / S&P -0.43% / 17.74% |
| 2017-Q12/3 |
WinLLY / S&P 15.13% / 6.07% |
WinLLY / S&P 6.97% / 3.67% |
LoseLLY / S&P -4.61% / 13.32% |
| 2016-Q42/3 |
LoseLLY / S&P -7.76% / 3.82% |
WinLLY / S&P 6.33% / 2.09% |
WinLLY / S&P 14.16% / 7.05% |
| 2016-Q32/3 |
LoseLLY / S&P 2.57% / 3.85% |
WinLLY / S&P 5.75% / 0.20% |
WinLLY / S&P 3.60% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | LLY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 61.28% | 20.78% |
| Annualized return | 61.28% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | LLY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 377.32% | 83.14% |
| Annualized return | 36.70% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | LLY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 1677.83% | 319.30% |
| Annualized return | 33.35% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |